OR WAIT null SECS
December 03, 2021
The companies will focus on the rapid development of polymerase chain reaction assays for emerging pathogens and potential health threats, including biological threats.
Fujifilm’s center adds local support in Suzhou, China for cell culture media optimization.
This collaboration aims to better understand Alzheimer’s and Parkinson’s disease and increase drug discovery and development success rates.
Moderna’s agreement with the UK government includes 29 million COVID-19 vaccine doses for delivery in 2022 and 31 million doses for delivery in 2023.
High price tags threaten to block patient access to potentially life-saving cures and treatments.
December 02, 2021
The new General Chapter “Nitrosamines Impurities” by USP became official on Dec. 2, 2021, in the United States Pharmacopeia—National Formulary.
EMA has fully validated the marketing authorization application for Atara Biotherapeutics’ off-the-shelf allogeneic T-cell therapy, tab-cel (tabelecleucel), with an approval decision expected in 2022.
Lean delivery offers a promising solution to supply and manufacturing bottlenecks by integrating project teams early on and widening the team’s field of view.
Chinook Therapeutics has formed a 50/50 joint venture with investors to develop kidney disease therapies in China.
Sartorius is investing €100 million (US$113 million) between 2021 and 2025 to expand capacities for production, innovation, and storage at its French facilities in Aubagne, Cergy, and Lourdes.